11 October 2019
New Oxford start-up is established to develop novel therapeutics based on the expertise of the Davis and Cornall groups at MRC HIU.
10 October 2019
New research by the Drakesmith group and collaborators shows that BMP inhibitors are able to reverse the main untreatable symptom of the disease.
7 October 2019
Sir Peter J Ratcliffe, former MRC WIMM group leader and currently Director for the Target Discovery Institute (Nuffield Department of Medicine) and Director of Clinical Research (Francis Crick Institute, London) has today been announced as a winner of the Nobel Prize in Physiology or Medicine.
18 September 2019
Study finds that shape of immune cells plays key role in responses to invaders.
12 September 2019
Many congratulations to Dr Simona Valletta, a postdoctoral research in MRC MHU, who was awarded an Intermediate Research Fellowship from the Kay Kendall Leukaemia Fund.
6 August 2019
Dr James Davies from our MRC Molecular Haematology Unit writes in The Conversation about genome editing, its power for good... and the ethical issues that we are already facing.
11 July 2019
Researchers at the MRC MHU have discovered the specific gene mutations that are required for the development of leukaemia in children with Down’s syndrome.